FTC Set To Take Enforcement Action Against Drugmakers Over Orange Book Patent Listings

Orange Book
FTC targets improper patent listings in FDA's Orange Book • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics